CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM NEW
Total 13F shares
2,871,703
Share change
-14,990
Total reported value
$1,271,751
Put/Call ratio
11%
Price per share
$0.44
Number of holders
25
Value change
+$32,857
Number of buys
7
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q1 2023

As of 31 Mar 2023, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,871,703 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, Bank of New York Mellon Corp, HRT FINANCIAL LP, NORTHERN TRUST CORP, SIGNATUREFD, LLC, and STATE STREET CORP. This page lists 25 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.